Drugs / Ibuprofen Arginine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy4 trials | ||||||
| Phase 4 | NCT06781489 Comparator | Feb → Mar 2025 | carpal tunnel syndrome | Universidad Europea de Madrid | Completed | No outcome recorded |
| Phase 4 | NCT06778759 Comparator | Feb → Mar 2025 | carpal tunnel syndrome | Universidad Europea de Madrid | Completed | No outcome recorded |
| Phase 4 | NCT04119739 Comparator | Apr → Jul 2020 | carpal tunnel syndrome | Francisco Unda Solano | Completed | No outcome recorded |
| Phase 4 | NCT04025203 Comparator | Aug → Nov 2019 | carpal tunnel syndrome | Francisco Unda Solano | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ibuprofen Arginine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06778759 ↗ |
| Route | Oral | “Oral tablet pharmaceutical treatment” NCT04025203 ↗ |